Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90. (Q35127277)
Jump to navigation
Jump to search
scholarly article
Language | Label | Description | Also known as |
---|---|---|---|
English | Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90. |
scholarly article |
Statements
1 reference
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90. (English)
1 reference
Jens R Sydor
1 reference
Emmanuel Normant
1 reference
Christine S Pien
1 reference
James R Porter
1 reference
Jie Ge
1 reference
Louis Grenier
1 reference
Roger H Pak
1 reference
Janid A Ali
1 reference
Marlene S Dembski
1 reference
Jebecka Hudak
1 reference
Jon Patterson
1 reference
Courtney Penders
1 reference
Melissa Pink
1 reference
Margaret A Read
1 reference
Jim Sang
1 reference
Caroline Woodward
1 reference
Yilong Zhang
1 reference
David S Grayzel
1 reference
Jim Wright
1 reference
John A Barrett
1 reference
Vito J Palombella
1 reference
Julian Adams
1 reference
Jeffrey K Tong
1 reference
7 November 2006
1 reference
103
1 reference
46
1 reference
17408-17413
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference